Niesvizky, R., Martínez-Baños, D., Jalbrzikowski, J., Christos, P., Furst, J., De Sancho, M., . . . Coleman, M. (2007). Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma. Leukemia & Lymphoma, 48(12), 2330. https://doi.org/10.1080/10428190701647887
Chicago Style (17th ed.) CitationNiesvizky, Ruben, et al. "Prophylactic Low-dose Aspirin Is Effective Antithrombotic Therapy for Combination Treatments of Thalidomide or Lenalidomide in Myeloma." Leukemia & Lymphoma 48, no. 12 (2007): 2330. https://doi.org/10.1080/10428190701647887.
MLA (9th ed.) CitationNiesvizky, Ruben, et al. "Prophylactic Low-dose Aspirin Is Effective Antithrombotic Therapy for Combination Treatments of Thalidomide or Lenalidomide in Myeloma." Leukemia & Lymphoma, vol. 48, no. 12, 2007, p. 2330, https://doi.org/10.1080/10428190701647887.